Patents-Review.com
ClassID:

20105 ⎘

A61K9/2036 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers Silicones; Polysiloxanes

Recent Application in this class:
#1
20250099439
2025-03-27

REGIMEN FOR SUPPRESSING ORGAN REJECTION

 #2
20240335399
2024-10-10

PHENYLEPHRINE HYDROCHLORIDE-CONTAINING TABLET, PREPARATION METHOD AND USE

 #3
20240293382
2024-09-05

MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE

 #4
20240238251
2024-07-18

A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof

 #5
20240082275
2024-03-14

Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine

 #6
20240082163
2024-03-14

Metformin tablet for relieving pain and reducing inflammation and manufacturing method thereof

 #7
20230390245
2023-12-07

A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof

 #8
20230321061
2023-10-12

Modified release pharmaceutical formulations comprising deferiprone

 #9
20230321060
2023-10-12

Modified release pharmaceutical formulations comprising deferiprone

 #10
20220249524
2022-08-11

Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine

 #11
20220249449
2022-08-11

Regimen for suppressing organ rejection

 #12
20210401860
2021-12-30

Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine

 #13
20210353648
2021-11-18

GRAPIPRANT UNIT DOSAGE FORMS

 #14
20210186994
2021-06-24

Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine

 #15
20200397756
2020-12-24

A STABLE PHARMACEUTICAL COMPOSITION OF POORLY SOLUBLE NONSTEROIDAL ANTIANDROGENS

 #16
20200297644
2020-09-24

Iniparib formulations and uses thereof

 #17
20200268721
2020-08-27

Regimen for suppressing organ rejection

 #18
20200085964
2020-03-19

Noncrushable pill formulations

 #19
20190314274
2019-10-17

Lyophilized pharmaceutical compositions for vaginal delivery

 #20
20190262392
2019-08-29

Effervescent dosage form

 #21
20190167600
2019-06-06

Biomolecule preservation

 #22
20190060283
2019-02-28

Pharmaceutical dosage forms

 #23
20180296592
2018-10-18

Effervescent dosage form

 #24
20180193319
2018-07-12

Regimen for suppressing organ rejection

 #25
20170296532
2017-10-19

COMPOSITIONS FOR CONTROL OF DRUG ABUSE

 #26
20170209487
2017-07-27

Effervescent dosage form

 #27
20170202808
2017-07-20

Pharmaceutical dosage forms

 #28
20170042835
2017-02-16

Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation

 #29
20170035656
2017-02-09

MULTI-LAYERED ORALLY DISINTEGRATING TABLET AND THE MANUFACTURE THEREOF

 #30
20160015692
2016-01-21

Regimen for supressing organ rejection

 #31
20150119422
2015-04-30

SIMETHICONE FORMULATION

 #32
20150004154
2015-01-01

Regimen for suppressing organ rejection

 #33
20140051733
2014-02-20

FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS

 #34
20140004162
2014-01-02

Transfer resistant cosmetic

 #35
20130028955
2013-01-31

SUSTAINED RELEASE ORAL MATRIX AND METHODS OF MAKING THEREOF

 #36
20120207801
2012-08-16

Transfer Resistant Cosmetic

 #37
20120035138
2012-02-09

Bisphosphonate Formulation

 #38
20110319441
2011-12-29

Manufacture of variable density dosage forms utilizing radiofrequency energy

 #39
20110318411
2011-12-29

MULTI-LAYERED ORALLY DISINTEGRATING TABLET AND THE MANUFACTURE THEREOF

 #40
20090169621
2009-07-02

Pharmaceutical excipient having improved compressibility

 #41
20090053162
2009-02-26

Bisphosphonate formulation

 #42
20080299193
2008-12-04

Pharmaceutical composition comprising eszoplicone

 #43
20080213356
2008-09-04

Pharmaceutical Composition Containing Hmg-Coa Reductase Inhibitor And Method For The Preparation Thereof

 #44
20070148244
2007-06-28

Drug delivery systems

 #45
20070065507
2007-03-22

Bisphosphonate formulation

 #46
20060292202
2006-12-28

Drug delivery device

 #47
20060204537
2006-09-14

Silicone blends and composites for drug delivery

 #48
20060008522
2006-01-12

Pharmaceutical excipient having improved compressibility

 #49
20050129728
2005-06-16

Sustained release pharmaceutical composition

 #50
20050013861
2005-01-20

Pharmaceutical excipient having improved compressibility